SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern

BELLEVUE, Wash., July 29 SCOLR Pharma, Inc.(Amex: DDD) today announced plans to release second quarter 2008 financialresults on Thursday, August 7, 2008, at 8:30 a.m. Eastern. Daniel O. Wilds,President and CEO of SCOLR Pharma, will host a conference call at 11:30 a.m.Eastern, to discuss the results.

Shareholders and other interested parties may participate in theconference call by dialing +1 888 680 0878 (domestic) or +1 617 213 4855(international) and entering access code 26733631, a few minutes before 11:30a.m. ET on August 7, 2008. The call will also be broadcast live on theInternet at www.streetevents.com, www.fulldisclosure.com or www.scolr.com.

A replay of the conference call will be accessible two hours after itscompletion through August 21, 2008, by dialing +1 888 286 8010 (domestic) or+1 617 801 6888 (international) and entering access code 55141034. The callwill also be archived for 90 days at www.streetevents.com,www.fulldisclosure.com or www.scolr.com.

Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialtypharmaceutical company. SCOLR Pharma's corporate objective is to combine itsformulation expertise and its patented CDT platform to develop novelpharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drugdelivery platform is based on multiple issued and pending patents and otherintellectual property for the programmed release or enhanced performance ofactive pharmaceutical ingredients and nutritional products. For moreinformation on SCOLR Pharma, please call 425.373.0171 or visithttp://www.scolr.com/.Contact: Investor Relations: Cameron Associates Kevin McGrath 212.245.4577 [email protected]

SOURCE SCOLR Pharma, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...